Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Danone SA is a France-based global food and beverage company. It operates through four segments: Essential Dairy and Plant-Based Products (EDP), Waters and Specialized Nutrition, including Early Life Nutrition and Medical Nutrition. EDP produces and distributes fresh fermented dairy products and other dairy specialties, plant-based products and beverages, coffee creamers and organic products; Waters sells bottled water and water sold in small and large containers; Early Life Nutrition offers baby formula (infant milk formula, follow-on milk, growing up milks), milk and fruit-based desserts, cereals, jars of baby food and ready-made baby food; Advanced Medical Nutrition offers adult or pediatric clinical nutrition products to be taken orally or through a tube in the event of malnutrition related to illness or other causes. The Company’s brands portfolio includes Activia, Actimel, Alpro, Danette, Danonino, Danio, evian, Volvic, Nutrilon/Aptamil, Nutricia, among others.

  • Revenue in EUR (TTM)27.66bn
  • Net income in EUR945.00m
  • Incorporated1955
  • Employees96.17k
  • Location
    Danone SA17 Boulevard Haussmann, PARIS Cedex 09PARIS 75009FranceFRA
  • Phone+33 144352020
  • Fax+33 144352480
  • Websitehttps://www.danone.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BN:PAR since
announced
Transaction
value
Promedica Sp zooDeal completed31 Mar 202331 Mar 2023Deal completed-0.94%--
Data delayed at least 15 minutes, as of Jun 02 2023 16:35 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.